Cite
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
MLA
Piero Barbanti, et al. “Predictors of Response to Anti-CGRP Monoclonal Antibodies: A 24-Week, Multicenter, Prospective Study on 864 Migraine Patients.” The Journal of Headache and Pain, vol. 23, no. 1, Nov. 2022, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s10194-022-01498-6.
APA
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Claudia Altamura, Florindo d’Onofrio, Cinzia Finocchi, Maria Albanese, Marco Aguggia, Renata Rao, Maurizio Zucco, Fabio Frediani, Massimo Filippi, Roberta Messina, Sabina Cevoli, Antonio Carnevale, Giulia Fiorentini, Stefano Messina, Francesco Bono, Paola Torelli, … for the Italian Migraine Registry study group. (2022). Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients. The Journal of Headache and Pain, 23(1), 1–12. https://doi.org/10.1186/s10194-022-01498-6
Chicago
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Claudia Altamura, Florindo d’Onofrio, Cinzia Finocchi, Maria Albanese, et al. 2022. “Predictors of Response to Anti-CGRP Monoclonal Antibodies: A 24-Week, Multicenter, Prospective Study on 864 Migraine Patients.” The Journal of Headache and Pain 23 (1): 1–12. doi:10.1186/s10194-022-01498-6.